Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov;215(5):539-547.
doi: 10.1016/j.ajog.2016.06.038. Epub 2016 Jul 1.

The role of screening, brief intervention, and referral to treatment in the perinatal period

Affiliations
Review

The role of screening, brief intervention, and referral to treatment in the perinatal period

Tricia E Wright et al. Am J Obstet Gynecol. 2016 Nov.

Abstract

Substance use during pregnancy is at least as common as many of the medical conditions screened for and managed during pregnancy. While harmful and costly, it is often ignored or managed poorly. Screening, brief intervention, and referral to treatment is an evidence-based approach to manage substance use. In September 2012, the US Centers for Disease Control and Prevention convened an Expert Meeting on Perinatal Illicit Drug Abuse to help address key issues around drug use in pregnancy in the United States. This article reflects the formal conclusions of the expert panel that discussed the use of screening, brief intervention, and referral to treatment during pregnancy. Screening for substance use during pregnancy should be universal. It allows stratification of women into zones of risk given their pattern of use. Low-risk women should receive brief advice, those classified as moderate risk should receive a brief intervention, whereas those who are high risk need referral to specialty care. A brief intervention is a patient-centered form of counseling using the principles of motivational interviewing. Screening, brief intervention, and referral to treatment has the potential to reduce the burden of substance use in pregnancy and should be integrated into prenatal care.

Keywords: alcohol; brief intervention; opioid use; pregnancy; referral to treatment; screening; substance use disorders; tobacco.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

Figures

FIGURE 1
FIGURE 1. Risk pyramid for assessment of substance use during pregnancy
SUD, substance use disorder.
FIGURE 2
FIGURE 2. Flow chart of screening, brief intervention, and referral to treatment (SBIRT) in practice
Flow chart of screening, brief intervention, and referral to treatment (SBIRT) in practice.

Comment in

References

    1. Substance Abuse and Mental Health Services Administration. Results from the 2013 national survey on drug use and health: summary of national findings, NSDUH series H-48, HHS publication no. (SMA) 14–4863. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2014.
    1. Viteri OA, Soto EE, Bahado-Singh RO, Christensen CW, Chauhan SP, Sibai BM. Fetal anomalies and long-term effects associated with substance abuse in pregnancy: a literature review. Am J Perinatol 2015;32:405–16. - PubMed
    1. Substance Abuse and Mental Health Services Administration. Prevention of substance abuse and mental illness. 2014. Available at: http://www.samhsa.gov/prevention. Accessed April 13, 2015.
    1. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA 2012;307:1934–40. - PubMed
    1. American College of Obstetricians and Gynecologists. At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. ACOG Committee opinion no. 422. Obstet Gynecol 2008;112:1449–60. - PubMed